PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
Experts urge support for PrEP after second Australian HIV case
Experts are emphasising the efficacy of the revolutionary pre-exposure prophylaxis (PrEP) medicine after a recent case of a Sydney man contracting HIV while taking...
Hotline data reveals Australians’ pharmacy questions
What are the health questions Australian most want answers to? Data from Medicines Line, the NPS MedicineWise pharmacist-staffed information hotline, has revealed common medical...
Three aspects of pharmacy practice addressed
Experts address the pharmacy practice questions that arise in relation to ECP salary negotiation, GP working relationships and commencing a RMMR service.
Q: I’m an...
Q&A: Shadow Federal Health Minister Catherine King
As a supporter of pharmacists, Catherine King MP is a firm believer in having a ‘broader’ role for pharmacists in Australia’s health system.
During her...
